EFFECT OF FENBUFEN ON THE ENTRY OF NEW QUINOLONES, NORFLOXACIN AND OFLOXACIN, INTO THE CENTRAL-NERVOUS-SYSTEM IN RATS

被引:16
作者
ICHIKAWA, N [1 ]
NAORA, K [1 ]
HAYASHIBARA, M [1 ]
KATAGIRI, Y [1 ]
IWAMOTO, K [1 ]
机构
[1] SHIMANE MED UNIV,DEPT PHARM,89-1 ENYA CHO,IZUMO,SHIMANE 693,JAPAN
关键词
D O I
10.1111/j.2042-7158.1992.tb03236.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The entry of two new quinolone antibacterial agents, norfloxacin and ofloxacin, into the central nervous system (CNS) of rats, and the effect of fenbufen on this was investigated. At various times after the administration of a bolus intravenous dose of norfloxacin or ofloxacin (10 mg kg-1) with or without fenbufen (20 mg kg-1), serum and cerebrospinal fluid (CSF) samples and whole brain were collected from the rats and the concentration of norfloxacin or ofloxacin in each sample was determined. Serum concentrations of both quinolones declined biexponentially with time and were significantly elevated by coadministration with fenbufen at the terminal phase. The fractions of these quinolones bound to serum protein were not altered by coadministration with fenbufen. Coadministered fenbufen raised the brain concentrations of both quinolones but did not affect their brain to serum unbound concentration ratios. In contrast, CSF to serum unbound concentration ratios as well as CSF concentrations of norfloxacin and ofloxacin were elevated by coadministration with fenbufen. Apparent diffusional clearances between blood and CSF of norfloxacin and ofloxacin estimated by the physiological model analysis increased by 1.9 and 2-6 times, respectively, after coadministration with fenbufen. These findings suggest that coadministered fenbufen may facilitate the entry of norfloxacin and ofloxacin into the CNS.
引用
收藏
页码:915 / 920
页数:6
相关论文
共 24 条
[1]   NORFLOXACIN AND SEIZURES [J].
ANASTASIO, GD ;
MENSCER, D ;
LITTLE, JM .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (02) :169-170
[2]   POTASSIUM EXCHANGE BETWEEN CEREBROSPINAL FLUID PLASMA AND BRAIN [J].
CSERR, H .
AMERICAN JOURNAL OF PHYSIOLOGY, 1965, 209 (06) :1219-&
[3]   HIPPOCAMPAL ACTIVITY IN THE PRESENCE OF QUINOLONES AND FENBUFEN INVITRO [J].
DIMPFEL, W ;
SPULER, M ;
DALHOFF, A ;
HOFMANN, W ;
SCHLUTER, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (06) :1142-1146
[4]  
GLOWINSKI J, 1966, J NEUROCHEM, V13, P665
[5]   ADVERSE DRUG-INTERACTIONS BETWEEN PYRIDONECARBOXYLIC ACIDS AND NONSTEROIDAL ANTIINFLAMMATORY DRUGS - CONVULSION AFTER ORAL OR INTRACEREBRAL ADMINISTRATION IN MICE [J].
HIRAI, S ;
TANAKA, K ;
MAKINO, S ;
NARITA, H .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1989, 109 (02) :119-126
[7]   DIFFUSION AND FLOW TRANSFER OF THEOPHYLLINE ACROSS THE BLOOD-BRAIN-BARRIER - PHARMACOKINETIC ANALYSIS [J].
KAROL, MD ;
VENGPEDERSEN, P ;
BRASHEAR, RE .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1983, 11 (03) :273-287
[8]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF CIPROFLOXACIN IN RAT-BRAIN AND CEREBROSPINAL-FLUID [J].
KATAGIRI, Y ;
NAORA, K ;
ICHIKAWA, N ;
HAYASHIBARA, M ;
IWAMOTO, K .
CHEMICAL & PHARMACEUTICAL BULLETIN, 1990, 38 (10) :2884-2886
[9]   ABSENCE OF PHARMACOKINETIC INTERACTION BETWEEN OFLOXACIN AND FENBUFEN IN RATS [J].
KATAGIRI, Y ;
NAORA, K ;
ICHIKAWA, N ;
HAYASHIBARA, M ;
IWAMOTO, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (10) :717-719
[10]  
KATAGIRI Y, 1989, JPN J HOSP PHARM, V15, P427